Prenatal Cell-free DNA Screening - Online
Course Directors: Megan A. Allyse, Ph.D., Mayo Clinic and Michael J. Dougherty, Ph.D., ASHG
Prenatal cell-free DNA screening (or cfDNA screening, often referred to as NIPT or noninvasive prenatal testing) is an increasingly popular and valuable tool for health professionals in obstetrics and gynecology, but proper clinical implementation is complex. In this three-module, hybrid-learning course, you will learn the benefits and limitations of prenatal cfDNA screening, how to interpret test results, and how to communicate with and manage patients who are considering cfDNA testing. This three-module course was developed in collaboration with Mayo Clinic and the American Society of Human Genetics (ASHG). The course is available free-of-charge and can be reviewed at the ASHG website here.
Obstetricians, nurses, and all medical practitioners who work with pregnant women to provide and/or discuss prenatal screening and testing
Upon conclusion of this program, participants should be able to:
- Explain the benefits and limitations of prenatal cfDNA screening
- Describe how to facilitate informed consent about prenatal cfDNA
- Interpret the results of prenatal cfDNA screening tests to appropriately manage patients
- Summarize the practical issues (costs, consent, and lab-specific) related to the use of cfDNA screening in practice
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) and the policies of Mayo Clinic and the American Society of Human Genetics (ASHG), speakers and moderators presenting in sessions that offer CME and CEU credit must disclose, prior to the start of their presentations, the existence of any relevant financial interests and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s), including diagnostic laboratories to be discussed during their presentation. All disclosures have been peer reviewed by the CME Subcommittee.
Megan Allyse, Ph.D., Mayo Clinic
Michael J. Dougherty, Ph.D., American Society of Human Genetics
Karen R. Hanson, M.S., MBA, CGC, American Society of Human Genetics
Kimberly Barr, M.S., LCGC, The Permanente Medical Group, Northern California
Kristi Borowski, M.D., Mayo Clinic
Jeff Greenberg, M.S., LCGC, Southern California Permanente Medical Group
Hilary Kershberg, M.S., LCGC, Southern California Permanente Medical Group
Laura Rust, M.S., CGC, Mayo Clinic
Katelynn Sagaser, M.S., CGC, Johns Hopkins
Myra J. Wick, M.D., Ph.D., Mayo Clinic
This activity is supported in part by unrestricted educational grants made to the ASHG Genomic Medicine Education Consortium, with current members:
- Quest Diagnostics
- Vertex Pharmaceuticals
Consortium members had no influence over the content of the program.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Mayo Clinic College of Medicine and Science and American Society of Human Genetics. The Mayo Clinic College of Medicine and Science is accredited by the ACCME to provide continuing medical education for physicians.
Mayo Clinic College of Medicine and Science designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To receive CME credit for this course, there is a $20 registration fee. Once registered, you will have access to a post-course assessment (5 multiple-choice questions). You must receive a score of 80% or higher (with one retake allowed) in order to claim credit.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance